Seshu Tyagarajan Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

Seshu Tyagarajan is Chief Technology Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 90,865 shares of CADL, which is worth approximately $622,425. The most recent transaction as insider was on Jun 25, 2025, when has been sold 5,353 shares (Common Stock) at a price of $4.67 per share, resulting in proceeds of $24,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.9K
6.26% 3M change
37.78% 12M change
Total Value Held $622,425

Seshu Tyagarajan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2025
BUY
Grant, award, or other acquisition
$24,998 $4.67 p/Share
5,353 Added 5.56%
90,865 Common Stock
Mar 17 2025
SELL
Open market or private sale
$275,871 $8.82 p/Share
31,278 Reduced 26.78%
85,512 Common Stock
Jan 15 2025
SELL
Open market or private sale
$103,404 $7.22 p/Share
14,322 Reduced 12.89%
96,790 Common Stock
Jan 08 2025
SELL
Open market or private sale
$119,559 $8.22 p/Share
14,545 Reduced 11.58%
111,112 Common Stock
Nov 29 2024
SELL
Open market or private sale
$92,987 $4.56 p/Share
20,392 Reduced 13.96%
125,657 Common Stock
Jul 17 2024
SELL
Open market or private sale
$96,085 $6.47 p/Share
14,851 Reduced 9.23%
146,049 Common Stock
Jul 11 2024
SELL
Open market or private sale
$79,580 $5.97 p/Share
13,330 Reduced 7.65%
160,900 Common Stock
Nov 28 2023
SELL
Payment of exercise price or tax liability
$15,595 $0.9 p/Share
17,328 Reduced 9.05%
174,230 Common Stock
Nov 26 2023
BUY
Grant, award, or other acquisition
-
104,516 Added 35.3%
191,558 Common Stock
Dec 09 2022
BUY
Open market or private purchase
$19,990 $1.93 p/Share
10,358 Added 43.68%
13,358 Common Stock
Dec 08 2022
BUY
Open market or private purchase
$5,070 $1.69 p/Share
3,000 Added 50.0%
3,000 Common Stock
Nov 28 2022
BUY
Grant, award, or other acquisition
-
73,684 Added 50.0%
73,684 Common Stock
ST

Seshu Tyagarajan

Chief Technology Officer
Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL